Evidence map›Paper›PMID 30089732›Full record

Trial reportJCI insight2018

Human adipose beiging in response to cold and mirabegron.

Brian S Finlin, Hasiyet Memetimin, Amy L Confides, Ildiko Kasza, Beibei Zhu, Hemendra J Vekaria, Brianna Harfmann, Kelly A Jones, Zachary R Johnson, Philip M Westgate and 4 more

2 registry-linked trialsOpen access · goldAbstract readRandomized Controlled TrialVideo-Audio Media
In one paragraph

Trial report in JCI insight, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 101 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
101citing papers in PubMed, 1 pooled it
10.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02596776 early_phase1completednot on this map

Cold Induced Changes in Human Subcutaneous White Adipose

TypeinterventionalSponsorPhilip KernRan2016 to 2018Enrolled26ConditionsObese, Normal Body Weight, Prediabetes, Metabolic SyndromeArmsFat biopsy, Propranolol and fat biopsy, heavy water and fat biopsy
NCT02919176 early_phase1completednot on this map

The Activation of Brown and Beige Fat and Role in Insulin Sensitivity

TypeinterventionalSponsorPhilip KernRan2016 to 2019Enrolled39ConditionsObese, Metabolic SyndromeArmsMirabegron, Pioglitazone, Mirabegron and Pioglitazone
3 · Its place in the literature

Who cites it

101 citing papers in PubMed, 1 synthesis or guideline pooled it, 188 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review

41 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Brian S FinlinThe Department of Internal Medicine, Division of Endocrinology, and the Barnstable Brown Diabetes and Obesity Center, and.
Hasiyet MemetiminThe Department of Internal Medicine, Division of Endocrinology, and the Barnstable Brown Diabetes and Obesity Center, and.
Amy L ConfidesDepartment of Rehabilitation Sciences, College of Health Sciences and Center for Muscle Biology, University of Kentucky, Lexington, Kentucky, USA.
Ildiko KaszaMcArdle Laboratory for Cancer Research, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Beibei ZhuThe Department of Internal Medicine, Division of Endocrinology, and the Barnstable Brown Diabetes and Obesity Center, and.
Hemendra J VekariaDepartment of Neuroscience.
Brianna HarfmannThe Department of Internal Medicine, Division of Endocrinology, and the Barnstable Brown Diabetes and Obesity Center, and.
Kelly A JonesThe Department of Internal Medicine, Division of Endocrinology, and the Barnstable Brown Diabetes and Obesity Center, and.
Zachary R JohnsonThe Department of Internal Medicine, Division of Endocrinology, and the Barnstable Brown Diabetes and Obesity Center, and.
Philip M WestgateCollege of Public Health, University of Kentucky, Lexington, Kentucky, USA.
Caroline M AlexanderMcArdle Laboratory for Cancer Research, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Patrick G SullivanDepartment of Neuroscience.
Esther E Dupont-VersteegdenDepartment of Rehabilitation Sciences, College of Health Sciences and Center for Muscle Biology, University of Kentucky, Lexington, Kentucky, USA.
Philip A KernThe Department of Internal Medicine, Division of Endocrinology, and the Barnstable Brown Diabetes and Obesity Center, and.
University of Kentucky · USSpinal Injuries Center · JPUniversity of Wisconsin–Madison · US

Funding

Kentucky Center for Clinical and Translational ScienceUL1TR001998 · NCATS · UNIVERSITY OF KENTUCKY · PI HARTMANN, KATHERINE E, KERN, PHILIP A · 2016 to 2025
$34.2M
The role of IKKß in linking obesity to adipose tissue inflammation and adipogeneP20GM103527 · NIGMS · UNIVERSITY OF KENTUCKY · PI MORRIS, ANDREW J · 2012 to 2017
$13.7M
Pilot Projects ProgramP30GM127211 · NIGMS · UNIVERSITY OF KENTUCKY · PI CASSIS, LISA A · 2018 to 2022
$5.7M
The activation of brown and beige fat and role in insulin sensitivityR01DK112282 · NIDDK · UNIVERSITY OF KENTUCKY · PI KERN, PHILIP A · 2016 to 2018
$1.6M
Cold Induced Changed in Human Subcutaneous White AdiposeR01DK107646 · NIDDK · UNIVERSITY OF KENTUCKY · PI KERN, PHILIP A · 2015 to 2017
$1.5M
NCATS NIH HHS UL1 TR001998NIDDK NIH HHS R01 DK107646NIDDK NIH HHS R01 DK112282NIGMS NIH HHS P20 GM103527NIGMS NIH HHS P30 GM127211
6 · The paper itself

Abstract

backgroundThe induction of beige adipocytes in s.c. white adipose tissue (WAT) depots of humans is postulated to improve glucose and lipid metabolism in obesity. The ability of obese, insulin-resistant humans to induce beige adipose tissue is unknown.

methodsWe exposed lean and obese research participants to cold (30-minute ice pack application each day for 10 days of the upper thigh) or treated them with the β3 agonist mirabegron. We determined beige adipose marker expression by IHC and quantitative PCR, and we analyzed mitochondrial bioenergetics and UCP activity with an Oxytherm system.

resultsCold significantly induced UCP1 and TMEM26 protein in both lean and obese subjects, and this response was not associated with age. Interestingly, these proteins increased to the same extent in s.c. WAT of the noniced contralateral leg, indicating a crossover effect. We further analyzed the bioenergetics of purified mitochondria from the abdominal s.c. WAT of cold-treated subjects and determined that repeat ice application significantly increased uncoupled respiration, consistent with the UCP1 protein induction and subsequent activation. Cold also increased State 3 and maximal respiration, and this effect on mitochondrial bioenergetics was stronger in summer than winter. Chronic treatment (10 weeks; 50 mg/day) with the β3 receptor agonist mirabegron induces UCP1, TMEM26, CIDEA, and phosphorylation of HSL on serine660 in obese subjects.

conclusionCold or β3 agonists cause the induction of beige adipose tissue in human s.c. WAT; this phenomenon may be exploited to increase beige adipose in older, insulin-resistant, obese individuals.

trial registrationClinicaltrials.gov NCT02596776, NCT02919176.

fundingNIH (DK107646, DK112282, P20GM103527, and by CTSA grant UL1TR001998).

Indexed as

AcetanilidesAdipose Tissue, BeigeAdrenergic beta-3 Receptor AgonistsAdultBiopsyCold TemperatureEnergy MetabolismFemaleHumansLipid MetabolismMaleMembrane ProteinsMiddle AgedObesitySubcutaneous FatThermogenesisAcetanilidesAdrenergic beta-3 Receptor AgonistsMembrane ProteinsmirabegronThiazolesTMEM26 protein, humanUCP1 protein, humanUncoupling Protein 1Adipose tissueClinical TrialsMetabolismObesity

Identifiers

PMID30089732
PMCPMC6129119
OpenAlexW2887354743

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.